Nakanishi (7716) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Achieved double-digit sales growth across all segments, with consolidated net sales up 21.3% year-over-year and EBITDA up 23.6% year-over-year.
Operating profit rose 39.1% to ¥4,675M, and net income attributable to owners of parent soared 803.9% to ¥3,980M, driven by higher revenues, improved forex gains, and absence of prior-year tax impacts.
Comprehensive income reached ¥4,652M, reversing a loss in the prior year.
Acra Cut and Intech acquisitions completed; their results to be consolidated from Q2 onward.
Financial highlights
Q1 net sales: ¥22,488M (+21.3% YoY); gross profit: ¥12,935M (+16.8% YoY); EBITDA: ¥5,876M (+23.6% YoY); operating profit: ¥4,675M (+39.1% YoY); ordinary profit: ¥5,548M (+111.2% YoY); net profit: ¥3,980M (+803.9% YoY).
EPS: ¥47.93 vs. ¥5.23 YoY.
Gross margin declined by 2.2pt YoY due to higher unrealized profits and U.S. tariffs.
Forex impact on net sales: +¥1,031M YoY.
Total assets increased to ¥165,775M, and net assets rose to ¥116,401M.
Outlook and guidance
FY2026 net sales forecast: ¥90,185M (+11.1% YoY); EBITDA: ¥21,854M (+9.8% YoY); operating income: ¥16,215M (+15.1% YoY); net profit: ¥11,193M.
Record-high sales expected for the sixth consecutive year, with growth in all business segments.
Q2 net sales forecast: ¥44,374M (+13.2% YoY); net profit: ¥5,308M (+51.2% YoY).
Dividend forecast for FY2026 is ¥60 per share, up from ¥54 in FY2025.
No changes to previously announced forecasts.
Latest events from Nakanishi
- Acquisition boosts U.S. market share and raises FY2026 sales and profit forecasts.7716
Acquisition presentation16 Mar 2026 - Net sales up 5.4% YoY, but DCI impairment led to a net loss; record sales and profit forecast for FY2026.7716
Q4 202512 Feb 2026 - Net sales up 3.8% YoY, but EBITDA and net income declined; guidance unchanged.7716
Q3 20256 Nov 2025 - Surgical growth offset flat sales, but net income dropped 50% amid currency headwinds.7716
Q2 20258 Aug 2025 - Sales surged 37.4% but net profit dropped 63.7%; outlook and dividend steady.7716
Q3 202413 Jun 2025 - Sales surged 36.4% year-over-year, but net income declined 11.9% amid mixed segment results.7716
Q2 202413 Jun 2025 - Sales rose, but profits plunged on forex and tax hits; outlook lowered amid global risks.7716
Q1 20256 Jun 2025 - Record sales, sharp profit drop; FY2025 sees higher dividend and cautious outlook.7716
Q4 20245 Jun 2025